Hsbc Holdings PLC Iovance Biotherapeutics, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 31,945 shares of IOVA stock, worth $170,586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,945
Previous 17,900
78.46%
Holding current value
$170,586
Previous $168,000
40.48%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IOVA
# of Institutions
331Shares Held
246MCall Options Held
3.95MPut Options Held
1.8M-
Vanguard Group Inc Valley Forge, PA27.5MShares$147 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$142 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$128 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$113 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$65.4 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $843M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...